Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

91.03 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗
Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets. 
Via The Motley Fool
Topics Energy Regulatory Compliance
News headline image
Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗
This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year ↗
Air Lease Corporation provides global airlines with commercial jet leasing, sales, and fleet management services across a diverse portfolio. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy ↗
Five9 delivers cloud-based contact center software for enterprises, serving clients across finance, healthcare, and technology sectors. 
Via The Motley Fool
News headline image
Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares ↗
Freshworks delivers cloud-based SaaS solutions for customer engagement, IT service management, and business process automation. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World’s Most Influential Leaders in Health
From GeneDx
Via Business Wire
News headline image
GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026
From GeneDx
Via Business Wire
News headline image
The Great Rotation: Small-Caps Stand Tall as AI Exhaustion Triggers Tech Rout
The stark divide in the financial markets reached a fever pitch today, January 29, 2026, as the long-anticipated "Great Rotation" finally appeared to take hold. While the tech-heavy Nasdaq Composite... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Great Rotation of 2026: Why Wall Street is Abandoning Big Tech for Main Street Small Caps
The dawn of 2026 has brought a seismic shift to global equity markets, as the long-anticipated "Great Rotation" finally takes hold. After nearly three years of dominance by a handful of mega-cap... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great AI Pivot: From Massive Build-Out to the Era of Operational ROI
As of January 27, 2026, the global financial markets are witnessing a profound transformation in the artificial intelligence narrative. While 2023 and 2024 were defined by a "land grab" for... 
Via MarketMinute
Topics Artificial Intelligence Economy Workforce
News headline image
The Great Rotation: Wall Street’s ‘Earnings Handoff’ Moves from Silicon Valley to Main Street
As of January 26, 2026, the financial landscape has undergone a seismic shift, marking the definitive end of the "Magnificent 7" era of uncontested dominance. For the first time in decades, the baton... 
Via MarketMinute
Topics Artificial Intelligence ETFs Earnings
News headline image
The Great Rotation: Small-Caps Set to Outpace ‘Magnificent 7’ in Historic Earnings Handoff
As of January 26, 2026, the long-standing hierarchy of the U.S. equity markets is undergoing its most significant transformation since the post-pandemic recovery. For the first time in years, the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
This biopharma firm targets rare diseases with both approved therapies and a pipeline of clinical-stage treatments. 
Via The Motley Fool
News headline image
Palisades Investment Initiated a Position in Travere Therapeutics Worth Over $5 Million. Is the Stock a Buy? ↗
This biopharma firm targets rare diseases with both approved therapies and a pipeline of clinical-stage treatments. 
Via The Motley Fool
News headline image
The Great Rotation of 2026: Why Wall Street is Betting Big on the Russell 2000
As of January 22, 2026, the financial landscape is witnessing a historic shift. After nearly two years of mega-cap technology dominance driven by the artificial intelligence boom, the "Great Rotation"... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
The Great Rotation: Small-Cap Stocks Surge in Early 2026 as Market Leadership Broadens
As of January 13, 2026, the financial landscape has undergone a dramatic transformation, marked by a decisive "regime shift" that many Wall Street analysts are calling the "Great Rotation." For the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The Great Rotation: Small-Caps Log Longest Winning Streak Against S&P 500 Since 2019
As of mid-January 2026, the U.S. equity markets are witnessing a historic recalibration that few analysts predicted eighteen months ago. The Russell 2000 index, the benchmark for American small-cap... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance
From GeneDx
Via Business Wire
News headline image
GeneDx and Komodo Health Partner to Build the World’s Most Complete Longitudinal Rare Disease Dataset
From GeneDx
Via Business Wire
News headline image
GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care
From GeneDx
Via Business Wire
News headline image
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care
From GeneDx
Via Business Wire
News headline image
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025
From GeneDx
Via Business Wire
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
As the financial markets open for the 2026 calendar year, BTIG has released its highly anticipated "Top Picks" report for the first half of the year, signaling a transition from the speculative fervor... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference
From GeneDx
Via Business Wire
News headline image
The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech
NEW YORK — In a dramatic shift that has redefined the market landscape of 2025, small-cap stocks have surged to historic levels, signaling what many analysts are calling the "Great Rotation." On... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025
As of mid-December 2025, the long-awaited "Great Rotation" in the financial markets has shifted from a theoretical prediction to a dominant reality. For the better part of the last three years,... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
GeneDx Holdings Corp. (NASDAQ:WGS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗
GeneDx (WGS) stock passes a strict growth screen, combining Minervini's strong trend template with accelerating earnings and sales fundamentals. 
Via Chartmill
News headline image
JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year
From GeneDx
Via Business Wire
News headline image
GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump ↗
The AI-powered genetic-testing company has been a strong performer. The CEO's recent move had more to do with accounting than conviction. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.